Did Avanir overmarket its brain drug to the elderly?

13th October 2017 Uncategorised 0

A newly published investigation alleges that Avanir Pharmaceuticals inappropriately marketed its neurological treatment Nuedexta to nursing home residents. The controversy over the drug, which has come under fire before, raises contentious issues related to off-label marketing and the relationships between physicians and drug companies.

More: Did Avanir overmarket its brain drug to the elderly?
Source: fierce